Clinical Trial Update: Outcomes After Intravenous Alteplase / Tenecteplase With or Without Shuxuetong Injection in Routine Clinical Practice

View source ↗

Summary

A completed real-world study comparing outcomes in ischemic stroke patients treated with intravenous alteplase or tenecteplase with or without Shuxuetong inject…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Activase (alteplase)
• Shuxuetong injection (shuxuetong)
• TNKASE (tenecteplase)

Snippet

Sponsor: Dongzhimen Hospital, Beijing | Conditions: Ischemic Stroke, Acute | Status: COMPLETED